BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Safwan M, Bourgleh MS, Aldoush M, Haider KH. Tissue-source effect on mesenchymal stem cells as living biodrugs for heart failure: Systematic review and meta-analysis. World J Cardiol 2024; 16(8): 469-483 [PMID: 39221190 DOI: 10.4330/wjc.v16.i8.469]
URL: https://www.wjgnet.com/1948-0210/full/v16/i8/469.htm
Number Citing Articles
1
Siddharth Shah, Huzaifa Sabir Nawaz, Muhammad Saeed Qazi, Hritvik Jain, Brandon Lucke-Wold. Living biodrugs and how tissue source influences mesenchymal stem cell therapeutics for heart failureWorld Journal of Cardiology 2024; 16(11): 619-625 doi: 10.4330/wjc.v16.i11.619
2
Moaz Safwan, Mariam Safwan Bourgleh, Khawaja Husnain Haider. Clinical experience with cryopreserved mesenchymal stem cells for cardiovascular applications: A systematic reviewWorld Journal of Stem Cells 2025; 17(3): 102067 doi: 10.4252/wjsc.v17.i3.102067
3
Omar T. F. Ahmed, Ziyad Tarek Ahmed, Abdulrahman W. Dairi, Maha Saad Zain Al-Abeden, Mohammed H. Alkahlot, Rana H. Alkahlot, Ghazi I. Al Jowf, Lars M. T. Eijssen, Khawaja Husnain Haider. The inconclusive superiority debate of allogeneic versus autologous MSCs in treating patients with HFrEF: a systematic review and meta-analysis of RCTsStem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04209-5
4
Ya-Lun Li, En-Guo Chen, Bing-Bing Ren. Umbilical cord-derived mesenchymal stromal cells: Promising therapy for heart failureWorld Journal of Cardiology 2025; 17(1): 101153 doi: 10.4330/wjc.v17.i1.101153